UCSF Expands Transit Pass Program Across its Workforce
UCSF is expanding Clipper BayPass to 36,000 employees and students, offering affordable, unlimited public transit across 24 Bay Area bus, rail and ferry services.
University of California San Francisco
Give to UCSFUCSF is expanding Clipper BayPass to 36,000 employees and students, offering affordable, unlimited public transit across 24 Bay Area bus, rail and ferry services.
Valerie Weaver's team discovers why stiff tissue is a risk factor for breast cancer: it spurs immune cells to release DNA-damaging chemicals, which cause the mutations that ultimately lead to cancer.
Andrew Ko, who led UCSF's trials of daraxonrasib based on discovery science, tells what to know about the medicine, the science behind it and what it means for patients. . On the heels of the drug's FDA approval, he
UCSF researchers helped test the first personalized mRNA cancer vaccine shown to prevent melanoma from returning or spreading, marking a breakthrough in cancer treatment.
Jason Nagata, MD, MSc, discusses the health dangers of excessive social media use on the health of children, in response to an August 2026 announcement of a $17.1 billion settlement regarding children and teen addiction to their platform.
An international research network led in North America by UC San Francisco (UCSF) has received a $9 million award from the Leducq Foundation, a cardiovascular research funding organization, to uncover
A study by Nevan Krogan and Matt State reveals protein interactions in the brain that are relevant to autism and epilepsy.
The UCSF Quantitative Biosciences Institute (QBI) has received a significant grant to fund autism-related research.
Forever chemicals are in our water and our blood. Now, UCSF researchers are understanding what happens when they reach our placentas and what that means for pregnancies, mothers and their babies.
UCSF welcomed its new and returning learners to the start of fall with white coat ceremonies and campus events.
Scientists made universal stem-cell-derived dendritic "immune teacher" cells that can be coated with a patient’s tumor proteins, creating a cancer vaccine that activated tumor-killing T cells in laboratory studies, patient samples, and mouse models.
UCSF is launching a national Center of Excellence for Eating Disorders that provides training and resources to providers, supported by a five-year grant from SAMHSA.
The upsurge in Parkinson's cases has been described as reaching pandemic levels. Caroline Tanner, MD, PhD, discusses her research, which explains why cases are rising, and what we can do to reduce our risk or slow progression.
UCSF is to become of the repository of a new class of industry documents due to a settlement in the state of Minnesota.
The number of low and intermediate-risk prostate cancer patients undergoing active surveillance in place of aggressive treatment has tripled to quadrupled over the last 20 years.
UCSF is celebrating continued recognition for its commitment to supporting the health and well-being of its workforce.
A new trial showed that inhaled cannabis was associated with a statistically significant 9% reduction in ectopic beats, which can sometimes signal a serious heart condition. While this finding wouldn't necessarily influence clinical decisions, it does indicate a need for further study and highlights the complex picture of the effects of cannabis on health.
MRIs are among the most accurate imaging tests used to diagnose brain tumors, and MRI-based monitoring of tumors guides critical treatment decisions. The clinical standard for measuring tumors
Orthopedic surgeon Dr. Nirav Pandya provides insight on how to ensure school-age children are prepared to play fall sports, including how to help them prevent early-season injuries.
UCSF reserachers discover why people with controlled HIV are at much higher risk for diabetes than HIV-negative people.
Chugai Pharmaceutical Co., Ltd. and UC San Francisco have entered into a Master Collaboration Agreement to advance drug discovery research. The multi-year agreement establishes a framework to
Researchers at UC San Francisco have developed a new method to predict how different types of breast cancer will respond to treatment, using patient data from an innovative clinical trial called I-SPY